title: Cross-immunizing potential of tumor MAGE-A epitopes recognized by HLA-A*02:01-restricted cytotoxic T lymphocytes.
abstract: Almost all melanoma cells express at least one member of the MAGE-A antigen family, making the cytotoxic T cells (CTLs) epitopes with cross-immunizing potential in this family attractive candidates for the broad spectrum of anti-melanoma immunotherapy. In this study, four highly homologous peptides (P264: FLWGPRALA, P264I9: FLWGPRALI, P264V9: FLWGPRALV, and P264H8: FLWGPRAHA) from the MAGE-A antigens were selected by homologous alignment. All four peptides showed high binding affinity and stability to HLA-A*02:01 molecules, and could prime CTL immune responses in human PBMCs and in HLA-A*02:01/K(b) transgenic mice. CTLs elicited by the four epitope peptides could cross-lyse tumor cells expressing the mutual target antigens, except MAGE-A11 which was not tested. However, CTLs induced by P264V9 and P264I9 showed the strongest target cell lysis capabilities, suggesting both peptides may represent the common CTL epitopes shared by the eight MAGE-A antigens, which could induce more potent and broad-spectrum antitumor responses in immunotherapy.
authors: Department of Immunology, Third Military Medical University, Chongqing, China.
authors: Ze-Min
authors: ZM
authors: Huang
authors: Zheng-Cai
authors: ZC
authors: Jia
authors: Jun
authors: J
authors: Tang
authors: Yi
authors: Y
authors: Zhang
authors: Yi
authors: Y
authors: Tian
authors: Dong-Jing
authors: DJ
authors: Ni
authors: Fang
authors: F
authors: Wang
authors: Yu-Zhang
authors: YZ
authors: Wu
authors: Bing
authors: B
authors: Ni
mesh_terms: D000818:Animals; D003429:Cross Reactions; D000939:Epitopes / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
chemical_list: D000939:Epitopes; D015234:HLA-A Antigens